Balyasny Asset Management LLC Argenx Se Transaction History

Balyasny Asset Management LLC

$58 Billion
Q3 2024

A detailed history of Balyasny Asset Management LLC transactions in Argenx Se stock. As of the latest transaction made, Balyasny Asset Management LLC holds 500 shares of ARGX stock, worth $311,910. This represents 0.0% of its overall portfolio holdings.

Number of Shares

500

Previous 45,164 98.89%

Holding current value

$311,910

Previous $19.4 Million 98.6%

% of portfolio

0.0%

Previous 0.04%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$434.22 - $551.9 $13.9 Million - $17.7 Million	-31,997 Reduced 70.85%	13,167 $7.14 Million
Q2 2024 Aug 14, 2024	SELL	$356.01 - $451.55 $4.23 Million - $5.37 Million	-11,882 Reduced 20.83%	45,164 $19.4 Million
Q1 2024 May 13, 2024	SELL	$356.95 - $413.29 $38.7 Million - $44.8 Million	-108,347 Reduced 65.51%	57,046 $22.5 Million
Q4 2023 Feb 14, 2024	BUY	$338.91 - $506.01 $24.8 Million - $37 Million	73,156 Added 79.31%	165,393 $62.9 Million
Q3 2023 Nov 14, 2023	SELL	$369.35 - $548.43 $24.9 Million - $36.9 Million	-67,281 Reduced 42.18%	92,237 $45.3 Million
Q2 2023 Aug 14, 2023	BUY	$360.14 - $422.58 $22.3 Million - $26.2 Million	61,993 Added 63.57%	159,518 $62.2 Million
Q1 2023 May 15, 2023	BUY	$334.23 - $403.65 $9.06 Million - $10.9 Million	27,100 Added 38.48%	97,525 $36.3 Million
Q4 2022 Feb 14, 2023	SELL	$342.17 - $402.31 $8.81 Million - $10.4 Million	-25,747 Reduced 26.77%	70,425 $26.7 Million
Q3 2022 Nov 14, 2022	SELL	$343.2 - $395.75 $14.5 Million - $16.8 Million	-42,325 Reduced 30.56%	96,172 $34 Million
Q2 2022 Aug 15, 2022	BUY	$269.58 - $378.88 $32.5 Million - $45.7 Million	120,637 Added 675.46%	138,497 $52.5 Million
Q1 2022 May 16, 2022	BUY	$254.45 - $351.06 $4.54 Million - $6.27 Million	17,860 New	17,860 $5.63 Million
Q4 2021 Feb 14, 2022	SELL	$272.01 - $353.03 $3.5 Million - $4.54 Million	-12,854 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$295.0 - $350.58 $3.79 Million - $4.51 Million	12,854 New	12,854 $3.88 Million

Others Institutions Holding ARGX

# of Institutions

400

Shares Held

30.9M

Call Options Held

376K

Put Options Held

489K

View Full List

About ARGENX SE

Ticker ARGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,323,800
Market Cap $34.5B
Description
argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...

More about ARGX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balyasny Asset Management LLC with notifications on news.

Account

Balyasny Asset Management LLC Argenx Se Transaction History